Device Trial Radar · NCT07940426
Title: Clinical Performance and Outcomes After Sphere Lens Transition
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
36
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Feb 2027
Study completion Feb 2027
Sponsor
- Lead sponsor
- CooperVision International Limited (CVIL)Not on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 16, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate subjective and clinical outcomes after transitioning from one sphere soft contact lens to another over a one-month period.
Conditions
- Astigmatism
Interventions
Fanfilcon A sphere Contact lensDevice
Participants are refit from their habitual sphere soft contact lenses to fanfilcon A sphere contact lenses and wear the lenses for approximately one month according to the study protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subjective ComfortTime frame: Baseline, 1 week, and 1 month.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Consultorio Optométrico
México, State of Mexico, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.